Dr. Clements is born in Indianapolis, Indiana to Enoch Hogate and Mary Charlene Clements.
Dr. Clements receives a Bachelor of Science from Purdue University in West Lafayette, Indiana.
Dr. Clements receives a Doctor of Medicine from the Indiana University School of Medicine in Indianapolis.
Dr. Clements begins a rotating internship at the University of California San Diego Medical Center (now UC San Diego Health).
Dr. Clements joins the U.S. Navy in China Lake, California, rising in the ranks to Lieutenant Commander.
Dr. Clements begins a residency in internal medicine at Cedars-Sinai Medical Center (now Cedars Sinai).
Dr. Clements begins a residency in rheumatology at the David Geffen School of Medicine at the University of California, Los Angeles.
Dr. Clements receives a fellowship in rheumatology from the Southern California chapter of the Arthritis Foundation.
Dr. Clements becomes an assistant professor of medicine in the Division of Rheumatology and the Department of Medicine at the David Geffen School of Medicine.
Dr. Clements serves as a Fellow in Clinical Pharmacology at Moffitt Hospital in San Francisco, California.
Dr. Clements is promoted to associate professor of medicine in residence at the David Geffen School of Medicine.
Dr. Clements receives a Philip and Jane Williams Fellowship in scleroderma.
Dr. Clements is promoted to full professor of medicine at the David Geffen School of Medicine.
Dr. Clements is cited among The Best Doctors in America for third time.
Dr. Clements receives a Master of Public Health from the Fielding School of Public Health at the University of California, Los Angeles.
Dr. Clements is named Emeritus Professor of Medicine and the David Geffen School of Medicine.
Dr. Clements is named Doctor of the Year by the National Office of the Scleroderma Foundation.
Dr. Clements is cited as one of the Top Doctors in America for the fifth consecutive year.
Dr. Clements publishes “The Scleroderma Lung Study #1” in the New England Journal of Medicine.
Dr. Clements publishes “The Scleroderma Lung Study #2” in The Lancet Respiratory Medicine.